NMPA Approval

Cefoperazone Sodium and Sulbactam Sodium for Injection(2:1)

Approval Number

国药准字H20065164

Company汕头金石粉针剂有限公司

Registration Date

May 26, 2020

Drug Information

Generic Name

注射用头孢哌酮钠舒巴坦钠(2:1)

Dosage Form

注射剂

Strength

0.75g(C25H27N9O8S2 0.5g与C8H11NO5S 0.25g)

Drug Type

化学药品

Registration Date

May 26, 2020

Company Information

Applicant Company

Company Name汕头金石粉针剂有限公司

Manufacturing Company

Company Name汕头金石粉针剂有限公司

Company Address

汕头市泰山路36号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用头孢哌酮钠舒巴坦钠(2:1) - NMPA 批准文号 | MedPath